Did not become law. It stopped in the House of Representatives's Ways and Means Committee on July 7, 2017. The 2017 session has ended.
2017 Regular Session
House Bill 2518
Requires pharmacy to report deidentified information to prescription monitoring program upon dispensing prescribed naloxone.
What it does
The synopsis the Legislative Assembly published with the bill.
Requires pharmacy to report deidentified information to prescription monitoring program upon dispensing prescribed naloxone. Requires pharmacy to report certain other identifying information to prescription monitoring program upon dispensing prescribed controlled substance classified in schedules II through IV. Requires information to be disclosed from prescription monitoring program to medical director or pharmacy director. Requires information to be disclosed from prescription monitoring program for certain other purposes. Requires licensing information of licensees who are authorized to prescribe or dispense controlled substances to be provided to Oregon Health Authority for purpose of qualifying licensees to report information to, or receive information from, prescription monitoring program. <b>Specifies that authority may require person requesting deidentified information from prescription monitoring program to enter into data use agreement with authority. <b>Requires authority, not less than once per year, to develop, through use of prescription monitoring program, criteria by which practitioner may be required to receive education or training on prescribing of opioids or opiates. Creates Prescription Monitoring Program Prescribing Practices Review Subcommittee for purposes of advising authority on development of criteria, reviewing practitioner's history to determine whether practitioner meets criteria and directing authority to provide educational material to practitioner who meets criteria.</b> Provides that authority may enter into agreements governing sharing and use of information reported to prescription monitoring program with regulatory authorities of other states that administer prescription monitoring programs. Becomes operative January 1, 2018. Declares emergency, effective on passage.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
2 co-sponsors
In the Senate
2 co-sponsors
Its course
January 9 to July 7, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action7 actions on 6 days
In the House of RepresentativesJan 9 to Jul 7 · stopped179 days
Waiting for a committeeJan 9 to Jan 178 days
Health CareJan 17 to Apr 2194 days
Ways and MeansApr 21 to Jul 7 · stopped77 days
Amendments
Each amendment offered, and what became of it.
House of Representatives committee amendmentAdopted
Adopted Apr 21
Text
Each version as the Legislative Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.
In the House of Representatives Jan 9 – Jul 7
- Jan 9Introduced
- Jan 17Sent to Health Care
- Mar 10Heard in Health Care
- Apr 17Heard in Health Care
- Apr 21Health Care recommended it as amended, and that it go to Ways and Means
- Sent to Ways and Means
- Jul 7Died when the session ended
All 7 actions, as published
- Jan 9First reading. Referred to Speaker's desk.House of Representatives
- Jan 17Referred to Health Care.House of Representatives
- Mar 10Public Hearing held.House of Representatives
- Apr 17Work Session held.House of Representatives
- Apr 21Recommendation: Do pass with amendments, be printed A-Engrossed, and be referred to Ways and Means.House of Representatives
- Apr 21Referred to Ways and Means by order of Speaker.House of Representatives
- Jul 7In committee upon adjournment.House of Representatives